{
    "clinical_study": {
        "@rank": "60607", 
        "brief_summary": {
            "textblock": "The purpose of this study is to see whether it is better to take delavirdine (DLV) plus\n      indinavir (IDV) plus zidovudine (ZDV) twice a day or three times a day."
        }, 
        "brief_title": "A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients", 
        "condition": "HIV Infections", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients are divided into 2 treatment groups; the groups are balanced with respect to viral\n      load.  Group A receives ZDV, DLV, and IDV 3 times daily.  Group B receives ZDV, DLV, and IDV\n      2 times daily.  Patients are evaluated for changes from baseline in viral load and CD4 cell\n      count."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        You may be eligible for this study if you:\n\n          -  Are HIV-positive.\n\n          -  Have a viral load (level of HIV in the blood) of at least 20,000 copies/ml.\n\n          -  Have a CD4 cell count of at least 50 cells/mm3.\n\n          -  Are at least 14 years old (consent of parent or guardian is required if under 18).\n\n        Exclusion Criteria\n\n        You will not be eligible for this study if you:\n\n          -  Have ever taken an anti-HIV drug other than ZDV.\n\n          -  Have taken ZDV for more than 1 month."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "14 Years"
        }, 
        "enrollment": "32", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002236", 
            "org_study_id": "228G", 
            "secondary_id": "M/3331/0072"
        }, 
        "intervention": [
            {
                "intervention_name": "Indinavir sulfate", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Delavirdine mesylate", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Zidovudine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Zidovudine", 
                "Reverse Transcriptase Inhibitors", 
                "Delavirdine", 
                "Indinavir", 
                "HIV Protease Inhibitors"
            ]
        }, 
        "keyword": [
            "Drug Therapy, Combination", 
            "Zidovudine", 
            "Drug Administration Schedule", 
            "HIV Protease Inhibitors", 
            "CD4 Lymphocyte Count", 
            "Indinavir", 
            "Delavirdine", 
            "Reverse Transcriptase Inhibitors", 
            "Anti-HIV Agents", 
            "Viral Load"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90027"
                    }, 
                    "name": "AIDS Healthcare Foundation"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94105"
                    }, 
                    "name": "UCSF AIDS Research Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10019"
                    }, 
                    "name": "Saint Luke's - Roosevelt Hosp Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pittsburgh", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "15213"
                    }, 
                    "name": "Anderson Clinical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Memphis", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "38165"
                    }, 
                    "name": "Univ of Tennessee / Div of Infect Dis / Dept of Med"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Annandale", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "22203"
                    }, 
                    "name": "Infectious Disease Physicians Inc"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "An Open-Label, Parallel Group, Pilot Study of Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of BID and TID Regimens of Delavirdine Mesylate, Zidovudine, and Indinavir Sulfate in HIV-1 Infected Individuals", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002236"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pharmacia and Upjohn", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Endpoint Classification: Pharmacokinetics Study, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2000"
    }, 
    "geocoordinates": {
        "AIDS Healthcare Foundation": "34.052 -118.244", 
        "Anderson Clinical Research": "40.441 -79.996", 
        "Infectious Disease Physicians Inc": "38.83 -77.196", 
        "Saint Luke's - Roosevelt Hosp Ctr": "40.714 -74.006", 
        "UCSF AIDS Research Institute": "37.775 -122.419", 
        "Univ of Tennessee / Div of Infect Dis / Dept of Med": "35.15 -90.049"
    }
}